A randomized clinical trial with a 0.6% amino acid/ 1.4% glycerol peritoneal dialysis solution

Glucose is an accepted osmotic agent for peritoneal dialysis (PD) although it has several drawbacks. Some of these drawbacks have been addressed by the introduction of solutions with low glucose degradation products and physiological pH in dual-chambered bags. Despite this achievement, there is a ne...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Peritoneal dialysis international 2004-05, Vol.24 (3), p.222-230
Hauptverfasser:	Van Biesen, W, Boer, W, De Greve, B, Dequidt, C, Vijt, D, Faict, D, Lameire, N
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Amino Acids - pharmacology Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Biological and medical sciences Dialysis Solutions - pharmacology Emergency and intensive care: renal failure. Dialysis management Female Follow-Up Studies Glomerulonephritis Glycerol - pharmacology Humans Intensive care medicine Kidney Diseases - metabolism Kidney Diseases - therapy Male Medical sciences Middle Aged Nephrology. Urinary tract diseases Nephropathies. Renovascular diseases. Renal failure Nutritional Status - drug effects Peritoneal Dialysis, Continuous Ambulatory Prospective Studies Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Surgery of the urinary system Time Factors Ultrafiltration Water-Electrolyte Balance - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!